Capvizr

Cerebral Raises $300 million Growth Round

Company profile · Healthcare & Life Sciences · Updated January 1, 2022

Cerebral raised $300M in Growth Round financing led by SoftBank. AI-first psychiatric care via telehealth. The new capital is framed around Expand measurement-based care and launch Cerebral for Employers product.

Growth Round$300 millionTotal tracked $600 millionSan Francisco, CA

What it does

AI-first psychiatric care via telehealth. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

200,000+ patients receiving medication management and therapy via AI-assisted telepsychiatry. Management framed the new capital around Expand measurement-based care and launch Cerebral for Employers product.

Trend impact

Psychiatric telehealth competing with Talkiatry for mental health medication management. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.

Funding history

  • January 1, 2022 · Growth Round · $300 million · SoftBank
  • January 1, 2022 · Series C · $300 million · SoftBank

Products & services

  • Healthcare & Life Sciences workflow monitoring tied to the funding announcement
  • Customer-facing product described on the company website
  • Operational tooling for healthcare & life sciences teams
  • Data capture and reporting across core business processes
  • Team expansion support funded by the latest round
Open Cerebral in the interactive Capvizr dashboard →